Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism

NCT04263038 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

276

Enrollment

OTHER

Sponsor class

Conditions

Pulmonary Embolism
Embolism
Embolism and Thrombosis
Lung Diseases
Cardiovascular Diseases
Respiratory Tract Diseases
Venous Thromboembolism
Anticoagulant-induced Bleeding
Bleeding

Interventions

DRUG: Rivaroxaban
DRUG: Placebo

Sponsor

Drahomir Aujesky

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]